Exploring Partnership Culture and its Impact on Outsourcing and Operational Strategy

Business strategist Peter Drucker famously said that “culture eats strategy for breakfast.” Of course, he didn’t mean that a strategy isn’t needed — it very much is. He meant that the best strategy would fail, unless it is supported by the right culture.

In this webinar, Sanofi and ICON discuss how they created a shared partnership/alliance culture, which has evolved both the outsourcing strategy and operating model. The result leverages the best of both organisations and aims at shaping a more efficient environment for clinical development.

Attendees will learn about the specific tools and methods used to develop and support the Sanofi/ICON partnership, including:

• Adaptation of the 9 Box Grid to assess cultural alignment and outsourcing and operational strategy, identifying areas of strength and opportunities for development
• An “ABCs of Culture” framework, designed to build cross-organizational cultural alignment

Register for this webinar to gain insights into partnership/alliance culture and its impact on outsourcing and operational strategy.

Speakers

Debbie Gilmore, Vice President, Strategic Alliance Management, ICON plc

Debbie Gilmore is Vice President, Strategic Alliance Management at ICON Clinical Research, and is based in the U.S. in Nashville, TN.  In this role, Debbie is responsible for ICON’s strategic partnership with Sanofi, which is Global One.  With over 20 years of clinical research experience, Debbie is focused on transforming project management and monitoring organisations, leveraging data-driven insights and risk-based methodologies.

Message Presenter

Kelly Simcox, Global Head, Clinical Operations R&D, Sanofi

Kelly Simcox is the Global Head of Clinical Operations at Sanofi U.S., and is based in Bridgewater, NJ. In this role, Kelly is responsible for global resources delivering >100 ongoing clinical trials/year; Kelly believes strongly in the power of strategic partnerships to achieve delivery. With over 29 years in the industry, Kelly’s background includes toxicology preclinical research, including various publications in peer-reviewed journals. In 2012, Kelly received the Rising Star award from Healthcare Businesswomen’s Association. Kelly has worked abroad and holds leadership roles representing Sanofi in cross-industry consortia. Recent external speaking events include virtual clinical trials workshop with The National Academies of Science, Engineering & Medicine and opening remarks at Gender Parity congress.

Message Presenter